These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2770138)

  • 21. [Capillary resistance raising action of Venoruton. Experimental data on the therapeutic effects of Venoruton].
    Gábor M
    Acta Pharm Hung; 1983 May; 53(3):115-20. PubMed ID: 6880764
    [No Abstract]   [Full Text] [Related]  

  • 22. [Sclerosing of varicose veins and additional medication. Are disease course and results affected by combined therapy? An experience report].
    Böhme D
    ZFA (Stuttgart); 1980 May; 56(13):953-9. PubMed ID: 7415464
    [No Abstract]   [Full Text] [Related]  

  • 23. [Venoruton--used not only in venopathies? Symposium on O-(beta-hydroxyethyl)-rutoside (=Venoruton) in vascular diseases].
    ZFA (Stuttgart); 1981 Sep; 57(26):1758-60. PubMed ID: 7303836
    [No Abstract]   [Full Text] [Related]  

  • 24. Influence of 0-(beta-hydroxyethyl)-rutin on the oedema-inhibiting effect of indomethacin.
    Blazsó G; Gábor M
    Acta Pharm Hung; 1994 Jul; 64(4):123-4. PubMed ID: 7976365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Influencing of xerostomia and asialia during psychotropic drug therapy with benzopyrone].
    Beck-Steiner G
    MMW Munch Med Wochenschr; 1979 Apr; 121(16):569-70. PubMed ID: 111051
    [No Abstract]   [Full Text] [Related]  

  • 26. [Characteristics of pulmonary gas exchange in children with acute suppurative destructive pneumonia after antioxidant therapy].
    Sergeev VM; Vaĭnberg MM; Ivanov AIu; Levin AB
    Grudn Khir; 1986; (3):50-2. PubMed ID: 3732881
    [No Abstract]   [Full Text] [Related]  

  • 27. [Benzopyrone in the therapy of postreconstructive edema. A clinical double-blind study].
    Becker HM; Niedermaier G; Orend KH
    Fortschr Med; 1985 Jun; 103(21):593-6. PubMed ID: 4018687
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pharmacodynamic research on the antianemia effect of rutozid combinations with iron and ascorbic acid].
    Cristea E; Mihele D; Oiţă N
    Rev Med Chir Soc Med Nat Iasi; 1985; 89(3):471-3. PubMed ID: 3832283
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapeutic investigations with venosan in veinous disease in the legs (author's transl)].
    Juon M; Messelhäuser I
    Schweiz Rundsch Med Prax; 1976 Jun; 65(24):755-8. PubMed ID: 981190
    [No Abstract]   [Full Text] [Related]  

  • 30. General practice treatment of symptoms of venous insufficiency with oxerutins. Results of a 660 patient multicentre study in the UK.
    Pulvertaft TB
    Vasa; 1983; 12(4):373-6. PubMed ID: 6362258
    [No Abstract]   [Full Text] [Related]  

  • 31. [Parieval in 52 cases of internal ear deafness].
    Martin H; Oudot J
    Ann Otolaryngol Chir Cervicofac; 1980 Dec; 97(12):1073-9. PubMed ID: 7247212
    [No Abstract]   [Full Text] [Related]  

  • 32. Toxic hepatitis due to benzo-pyrone.
    Faurschou P
    Hum Toxicol; 1982 Mar; 1(2):149-50. PubMed ID: 7173895
    [No Abstract]   [Full Text] [Related]  

  • 33. Can the routine treatment of Graves' orbitopathy be efficiently supplemented by the administration of Venalot?
    Frank K; Ding G; Raue F; Ziegler R
    Dev Ophthalmol; 1989; 20():127-9. PubMed ID: 2687048
    [No Abstract]   [Full Text] [Related]  

  • 34. A double blind three center clinical trial on the short-term efficacy of 0-(beta-hydroxyethyl)-rutosides in patients with post-thrombotic syndrome.
    de Jongste AB; Jonker JJ; Huisman MV; ten Cate JW; Azar AJ
    Thromb Haemost; 1989 Nov; 62(3):826-9. PubMed ID: 2688186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative study of vincamine and rutovincine (LJ 533) on the cerebral hyperemia in rats with chronic hypoxia].
    Huyen VN; Reichart E; Duval D; Moricard Y
    Sem Hop Ther; 1977; 53(7-8):363-7. PubMed ID: 594751
    [No Abstract]   [Full Text] [Related]  

  • 36. Paroven: not much effect in trials.
    Drug Ther Bull; 1992 Jan; 30(2):7-8. PubMed ID: 1555498
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiaggregatory effects of flavonoids in vivo and their influence on lipoxygenase and cyclooxygenase in vitro.
    Swies J; Robak J; Dabrowski L; Duniec Z; Michalska Z; Gryglewski RJ
    Pol J Pharmacol Pharm; 1984; 36(5):455-63. PubMed ID: 6442773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [An evaluation of the effect of magnetic-laser therapy on external respiratory function in complicated forms of acute pneumonia in children].
    Gaĭdashev EA; Lebedev KN; Khristoforov VN; Biriukov VV; Gatkin EIa
    Vopr Kurortol Fizioter Lech Fiz Kult; 1995; (3):12-4. PubMed ID: 7483376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative investigations on the treatment of the varicose syndrome with 4-methyl-6,7-(bis-beta-diethyl-aminoethoxy)-coumarine hydrochloride (oxamarine), with the disodium salt of disulphuric ester of 4-methyl-aesculetol and with tri-hydroxy-ethylrutoside (troxerutin).
    Frandoli G; Turazza G; Spreafico PL
    Panminerva Med; 1972 Sep; 14(9):290-5. PubMed ID: 4618898
    [No Abstract]   [Full Text] [Related]  

  • 40. [The influence of the combination of coumarin and troxerutin on infantile blood parameter in lactation period. Short communication (author's transl)].
    Krajnovic P
    Arzneimittelforschung; 1977 Jul; 27(7):1499-500. PubMed ID: 578482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.